SCHEMBL5159255

SCHEMBL5159255

CCCCON(C)C(N)=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.41
ATM Q13315 1/20 0.39
ADRB2 P07550 1/20 0.37
ADRB1 P08588 1/20 0.37
ADRB3 P13945 1/20 0.37
MAPT P10636 1/20 0.37
RAB9A P51151 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
TSHR P16473 2/20 0.36
HPGD P15428 1/20 0.36
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
DNM1 Q05193 1/20 0.35
HCAR2 Q8TDS4 1/20 0.34
LMNA P02545 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
PDE4D Q08499 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28795023 0.86
SCHEMBL11315083 0.82 ALDH1A1 (0.44) ALDH1A1ATMTSHRHPGDDNM1
SCHEMBL18359032 0.80 ALDH1A1 (0.48) ALDH1A1ATMTSHRHPGDHCAR2
SCHEMBL5158546 0.78 ALDH1A1 (0.41) ALDH1A1ATMTSHRHPGDDNM1
SCHEMBL15281943 0.78 ALDH1A1 (0.41) ALDH1A1ATMTSHRHPGDDNM1
SCHEMBL23768611 0.77 ALDH1A1 (0.45) ALDH1A1ATMTSHRHPGDDNM1
SCHEMBL7648067 0.77
SCHEMBL5156823 0.76 ALDH1A1 (0.36) ALDH1A1ATMADRB2ADRB1ADRB3
SCHEMBL2838639 0.74 TSHR (0.50) ALDH1A1ATMTSHRHPGDDNM1
SCHEMBL238944 0.74 TSHR (0.43) ALDH1A1ATMTSHRHPGDDNM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017002087-A1 NITROGEN CONTAINING BICYCLIC COMPOUNDS AND THEIR USE IN TREATMENT OF BACTERIAL INFECTIONS WOCKHARDTLIMITED (IN) 2017-01-05 WO disclosed
US-20160022844-A1 TETRAHYDROXAMATE CHELATORS OF ZIRCONIUM89 AND NIOBIUM90 FOR USE IN DIAGNOSTIC APPLICATIONS The USA, as represented by the secretary, Department of Health & Human Service (US) 2016-01-28 US disclosed
EP-1057852-B1 Polyester film for decorative plate or decorative sheet MITSUBISHI POLYESTER FILM CORP (JP) 2007-02-14 EP disclosed
EP-0839856-B1 Polyester film for decorative plate or decorative sheet MITSUBISHI POLYESTER FILM CORP (JP) 2003-12-17 EP disclosed
EP-1057852-A2 Polyester film for decorative plate or decorative sheet Mitsubishi Polyester Film Corporation (JP) 2000-12-06 EP disclosed
US-6096410-A POLYESTER FILM FOR DECORATIVE PLATE OR HAS OPTICAL DENSITY OF 0.1 TO 5.0, A B VALUE OF NOT LESS THAN-0.5 AND LONGITUDINAL AND TRANSVERSE HEAT SHRINKAGE PERCENTAGES OF NOT LESS THAN -10.0% AND NOT MORE THAN +10.0% AFTER HEAT TREATMENT MITSUBISHI POLYESTER FILM CORPORATION (JP) 2000-08-01 US disclosed
US-5932320-A Polyester film for decorative plate or decorative sheet MITSUBISHI POLYESTER FILM CORPORATION (JP) 1999-08-03 US disclosed
EP-0839856-A2 Polyester film for decorative plate or decorative sheet Mitsubishi Polyester Film Corporation (JP) 1998-05-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160022844-A1 TETRAHYDROXAMATE CHELATORS OF ZIRCONIUM89 AND NIOBIUM90 FOR USE IN DIAGNOSTIC APPLICATIONS SLC39A3, SLC39A11, SLC39A7 ALDH1A1 3545/4885ATM 4443/4885ADRB2 3256/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.